Uterotonic drug quality: An assessment of the potency of injectable uterotonic drugs purchased by simulated clients in three districts in Ghana

BMJ Open

Volumn 2, Issue 3, 2012, Pages

  Stanton, Cynthia ^a   Koski, Alissa ^a   Cofie, Patience ^b   Mirzabagi, Ellie ^a   Grady, Breanne L ^c   Brooke, Steve ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b PATH   (Ghana)

^c PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COUNTERFEIT DRUG; ERGOMETRINE; OXYTOCIN;

AMPOULE; ARTICLE; DRUG MARKETING; DRUG POTENCY; DRUG QUALITY; GHANA; HEALTH CARE ACCESS; PRESCRIPTION;

EID: 84862234777     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2011-000431     Document Type: Article

References (12)

1. WHO. WHO Model List of Essential Medicines; 16th List (Updated). Geneva, 2010. http://www.who.int/medicines/publications/essentialmedicines/en/index.html
2. WHO. WHO Statement Regarding the Use of Misoprostol for Postpartum Haemorrhage Prevention and Treatment. Geneva: Department of Reproductive Health and Research, 2009.
3. WHO. WHO List of Priority Medicines for Mothers and Children. Department of Maternal, Newborn, Child and Adolescent Health, 2011.
4. Stability of Injectable Oxytocics in Tropical Climates; Results of Field Surveys and Simulation Studies on Ergometrine, Methylergometrine and Oxytocin. Geneva: Action Program on Essential Drugs, World Health Organisation, 1993.
5. de Groot AN, Hekster YA, Vree TB, et al. Ergometrine and methylergometrine tablets are not stable under simulated tropical conditions. J Clin Pharm Ther 1995;20:109-13.
6. de Groot AN, Hekster YA, Vree TB, et al. Oxytocin and desaminooxytocin tablets are not stable under simulated tropical conditions. J Clin Pharm Ther 1995;20:115-19.
7. Hogerzeil HV, Battersby A, Srdanovic V, et al. Stability of essential drugs during shipment to the tropics. BMJ 1992;304:210-12.
8. Nazerali H, Hogerzeil HV. The quality and stability of essential drugs in rural Zimbabwe: controlled longitudinal study. BMJ 1998;317:512-13. (Pubitemid 28379604)
9. Waddington CM, Coleman NA. Evaluation of the MeTA Phase 1 2009-2010; Ghana Country Report. London: HLSP, 2010.
10. Ghana Health Service, Ghana Statistical Service, Macro International. Ghana Maternal Health Survey, 2009. Calverton, Maryland, USA.
11. Makinen MS, Bitran S, Adjei R, et al. Private Health Sector Assessment in Ghana. Washington DC: The World Bank, 2010.
12. Fernandez MM, Coeytaux F, de Leon RG, et al. Assessing the global availability of misoprostol. Int J Gynaecol Obstet 2009;105:180-6.